BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 18, 2012
View Archived Issues
GLA screened for adjuvant efficacy in an experimental malaria model
Read More
University of Michigan patents novel antibodies binding to integrin alpha-2
Read More
Roche and Siena Biotech synthesize novel beta-secretase inhibitors
Read More
Cat-PAD proves safe and effective in cat allergic subjects
Read More
Treatment begins in first phase II trial of IPH-2102 for AML
Read More
Japanese researchers present novel adenovirus vectors for cancer
Read More
Ajou University discloses novel adult stem cell lines
Read More
Spanish researchers synthesize new protein kinase inhibitors
Read More
Bayer Intellectual Property describes novel MKNK1 inhibitors
Read More
New RNA-directed RNA polymerase inhibitors divulged by Roche
Read More
Amakem prepares novel protein kinase inhibitors
Read More
Amarin completes dosing in fixed-dose Vascepa/statin study
Read More
Ironwood Pharmaceuticals and Forest Laboratories launch Linzess
Read More
Alexza's MAA for Adasuve receives positive opinion from EMA advisory committee
Read More
Intracellular mechanisms of glycolysis-mediated tumor growth discovered
Read More
Helix and Merck & Co. terminate agreement on topical interferon alfa-2b products
Read More
Roche's Perjeta receives CHMP recommendation for approval
Read More
LX-1033 receives fast track status from the FDA
Read More
Evotec licenses portfolio of NMDA antagonists to Janssen
Read More
Phenex collaborates with Janssen on autoimmune and chronic inflammatory disorders
Read More
E-selectin inhibitor GMI-1271 shows promise in vivo
Read More
MedImmune to develop therapies against serious bacterial infections
Read More
Boehringer Ingelheim's anti-CD33 MAb enters phase I AML study
Read More
Vivalis and Intercell agree to merge
Read More
Lundbeck to divest non-core products to Recordati
Read More
Invion reports on pre-IND meeting for INV-103
Read More
Fibrocell Science to begin phase II azficel-T trial for restrictive burn scars
Read More
GSK's four-strain seasonal influenza vaccine Fluarix Quadrivalent approved for use in U.S.
Read More